Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 in New Jersey
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in New Jersey
| Provider | Medicare | Services |
|---|---|---|
| Bioreference Health, Llc | $20.38 | 5.8K |
| Quest Diagnostics Incorporated | $20.39 | 5.4K |
| Laboratory Corporation Of America... | $20.39 | 3.6K |
| Accu Reference Medical Lab, Llc | $20.37 | 1.1K |
| Centers Lab Nj Llc | $20.39 | 271 |
| Chemisys Laboratories, Llc | $20.39 | 262 |
| Lincoln Diagnostics Llc | $20.39 | 133 |
| Rnj Services, Inc | $20.39 | 112 |
| Ez Clinical Laboratory Inc | $20.39 | 54 |
New Jersey Pricing in Context
In New Jersey, CPT code 86301 (Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9) carries an average Medicare payment of $20.38 — 0% above the national benchmark of $20.37. 22 providers across the state submitted claims for this procedure in 2023, performing 16.9K total services. Individual payments in NJ ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in New Jersey is $127.39, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New Jersey sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in New Jersey lands near $51.98, with self-pay cash prices typically around $50.32. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 cost in New Jersey?
The average Medicare payment for Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 in New Jersey is $20.38, which is 0% above the national average of $20.37. Providers in NJ typically bill $127.39 for this procedure.
What does Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 cost with insurance in New Jersey?
With commercial insurance in New Jersey, Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 costs an estimated $51.98. Without insurance, the estimated cash price is $50.32. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 in New Jersey?
22 providers in New Jersey billed Medicare for Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 in 2023, performing 16.9K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 cheaper in New Jersey than the national average?
No — Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 costs 0% above the national average in New Jersey. The state average Medicare payment is $20.38 compared to $20.37 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.